178 related articles for article (PubMed ID: 19800376)
1. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
Maher S; Leonard TW; Jacobsen J; Brayden DJ
Adv Drug Deliv Rev; 2009 Dec; 61(15):1427-49. PubMed ID: 19800376
[TBL] [Abstract][Full Text] [Related]
2. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
[TBL] [Abstract][Full Text] [Related]
3. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
4. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs.
Raoof AA; Ramtoola Z; McKenna B; Yu RZ; Hardee G; Geary RS
Eur J Pharm Sci; 2002 Nov; 17(3):131-8. PubMed ID: 12393140
[TBL] [Abstract][Full Text] [Related]
5. Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine.
Sadeghi AM; Avadi MR; Ejtemaimehr Sh; Abashzadeh Sh; Partoazar A; Dorkoosh F; Faghihi M; Rafiee-Tehrani M; Junginger HE
J Control Release; 2009 Feb; 134(1):11-7. PubMed ID: 19014985
[TBL] [Abstract][Full Text] [Related]
6. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate.
Raoof AA; Chiu P; Ramtoola Z; Cumming IK; Teng C; Weinbach SP; Hardee GE; Levin AA; Geary RS
J Pharm Sci; 2004 Jun; 93(6):1431-9. PubMed ID: 15124202
[TBL] [Abstract][Full Text] [Related]
8. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
9. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET.
Leonard TW; Lynch J; McKenna MJ; Brayden DJ
Expert Opin Drug Deliv; 2006 Sep; 3(5):685-92. PubMed ID: 16948563
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of intestinal absorption of 2-methyl cytidine prodrugs.
Cianetti S; Cooper VB; Attenni B; Pucci V; Fiore F; Giuliano C; Laufer R; Gardelli C; Monteagudo E; Narjes F; Pearce GE; Rowley M
Drug Deliv; 2010 May; 17(4):214-22. PubMed ID: 20233089
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
J Drug Target; 2005 Dec; 13(10):573-83. PubMed ID: 16390818
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
Aguirre TA; Rosa M; Coulter IS; Brayden DJ
Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
[TBL] [Abstract][Full Text] [Related]
16. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
Wang X; Maher S; Brayden DJ
Ther Deliv; 2010 Jul; 1(1):75-82. PubMed ID: 22816121
[TBL] [Abstract][Full Text] [Related]
17. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
[TBL] [Abstract][Full Text] [Related]
18. [Oral absorption enhancers of Ophiopogon japonicas polysaccharides].
Lin X; Lu Z; Xu D; Feng Y; Shen L
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1498-502. PubMed ID: 19777832
[TBL] [Abstract][Full Text] [Related]
19. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
Fasano A
Mol Genet Metab; 1998 May; 64(1):12-8. PubMed ID: 9682213
[TBL] [Abstract][Full Text] [Related]
20. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
